Impax Asset Management Group plc Boosts Stake in SI-BONE, Inc. (NASDAQ:SIBN)

Impax Asset Management Group plc lifted its holdings in shares of SI-BONE, Inc. (NASDAQ:SIBN) by 1.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 766,761 shares of the company’s stock after buying an additional 8,240 shares during the period. Impax Asset Management Group plc owned approximately 1.83% of SI-BONE worth $10,750,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Champlain Investment Partners LLC boosted its holdings in shares of SI-BONE by 14.7% during the 3rd quarter. Champlain Investment Partners LLC now owns 2,800,073 shares of the company’s stock valued at $39,145,000 after acquiring an additional 358,821 shares during the last quarter. Bellevue Group AG boosted its holdings in SI-BONE by 4.1% in the third quarter. Bellevue Group AG now owns 1,444,109 shares of the company’s stock worth $20,189,000 after purchasing an additional 56,500 shares during the last quarter. State Street Corp grew its position in SI-BONE by 5.1% in the 3rd quarter. State Street Corp now owns 1,081,871 shares of the company’s stock worth $15,125,000 after purchasing an additional 52,972 shares during the period. Wellington Management Group LLP raised its stake in SI-BONE by 3.5% during the 3rd quarter. Wellington Management Group LLP now owns 1,028,238 shares of the company’s stock valued at $14,375,000 after buying an additional 35,220 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of SI-BONE by 3.4% during the 3rd quarter. Geode Capital Management LLC now owns 924,044 shares of the company’s stock valued at $12,921,000 after buying an additional 30,005 shares during the period. 98.11% of the stock is currently owned by institutional investors.

SI-BONE Stock Performance

Shares of SIBN opened at $17.47 on Tuesday. SI-BONE, Inc. has a 52 week low of $11.70 and a 52 week high of $20.60. The company has a quick ratio of 7.22, a current ratio of 8.25 and a debt-to-equity ratio of 0.22. The stock has a market cap of $732.66 million, a price-to-earnings ratio of -18.99 and a beta of 1.17. The business has a 50-day simple moving average of $15.73 and a two-hundred day simple moving average of $14.69.

SI-BONE (NASDAQ:SIBN) last released its earnings results on Monday, February 24th. The company reported ($0.11) EPS for the quarter, topping analysts’ consensus estimates of ($0.16) by $0.05. SI-BONE had a negative net margin of 23.82% and a negative return on equity of 22.51%. On average, analysts expect that SI-BONE, Inc. will post -0.78 EPS for the current year.

Analyst Ratings Changes

Several research analysts have issued reports on SIBN shares. Truist Financial raised their target price on SI-BONE from $16.00 to $18.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. Needham & Company LLC reissued a “buy” rating and issued a $19.00 price objective on shares of SI-BONE in a report on Monday, January 13th. Six research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $23.00.

Insider Activity

In related news, insider Anthony J. Recupero sold 3,670 shares of SI-BONE stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $13.90, for a total transaction of $51,013.00. Following the sale, the insider now owns 222,814 shares of the company’s stock, valued at approximately $3,097,114.60. This trade represents a 1.62 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Anshul Maheshwari sold 5,304 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $13.91, for a total value of $73,778.64. Following the completion of the transaction, the chief financial officer now owns 189,319 shares of the company’s stock, valued at $2,633,427.29. The trade was a 2.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 9,311 shares of company stock worth $130,356 in the last three months. Company insiders own 3.90% of the company’s stock.

SI-BONE Company Profile

SI-BONE, Inc, a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products.